5-Formyl salicylaldehyde as a linker for the synthesis of benzofuran containing insulin sensitivity enhancer compounds

Tetrahedron Letters

Volumn 37, Issue 52, 1996, Pages 9267-9270

  Stille, John R ^a   Ward, Jeffrey A ^a   Leffelman, Cindy ^a   Sullivan, Kevin A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE;

ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; INSULIN SENSITIVITY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0030599686     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)82938-3     Document Type: Article

References (29)

1. 1. For reviews in this area, see: (a) Steiner, K. E.; Lien, E. L. Prog. Med. Chem. 1987, 24, 209.
2. (b) Mohrbacher, R. J.; Kiorpes, T. C.; Bowden, C. R. Ann. Rep. Med. Chem. 1987, 22, 213.
3. (c) Larson, E. R.; Clark, D. A.; Stevenson, R. W. Ann. Rep. Med. Chem. 1990, 25, 205.
4. (d) Colca, J. R.; Tanis, S. P. Ann. Rep. Med. Chem. 1992, 27, 219.
5. 2. Clark, D. A.; Goldstein, S. W., et al. J. Med. Chem. 1991, 34, 319.
6. 3. Iijima, I.; Ozeki, M.; Okumura, K.; Inamasu, M., Eur. Pat. Appl. EP 0 283,036, 1988; Chem. Abst 1989, 110, 75529c.
7. 4. Iijima, I.; Ozeki, M.; Okumura, K.; Inamasu, M. Eur. Pat. Appl. EP 283,035, 1988 and U.S. Pat. 4 824 833; Chem. Abstr. 1989, 110, 57567p.
8. 5. (a) Haigh, D. B.; Hindley, R. M. Eur. Pat. Appl. EP 299,620, 1989; Chem. Abstr. 1989, 111, 7394a.
9. (b) Goldstein, S. W.; Hulin, B. WO 93/00,343, 1993; Chem. Abstr. 1993, 118, 191732c.
10. (c) de Nanteuil, G.; Duhault, J.; Espinal, J.; Ravel, D. Eur. Pat. Appl. EP 559,571, 1993; Chem. Abstr. 1994, 120, 77273v.
11. 6. Aizawa, Y.; Kanai, T.; Fujita, T.; Horikoshi, H.; Yoshioka, T. Heterocycles 1991, 32, 285.
12. 7. (a) Thoer, A.; Denis, G.; Delmas, M.; Gaset, A. Synth. Commun. 1988, 18, 2095.
13. (b) Snini, A.; Fahimi, A.; Mouloungui, Z.; Delmas, M.; Gaset, A. J. Chromatogr. 1992, 590, 369.
14. 8. Hatano, K.; Matsui, M. Agr. Biol. Chem. 1973, 37, 2917.
15. 9. (a) Mathew, T. V.; Chauhan, V. S. Ind. J. Chem. 1987, 26B, 1071.
16. (b) Tanoue, Y.; Terada, A.; Matsumoto, Y. Bull. Chem. Soc. Jpn. 1989, 62, 2736.
17. (c) Weerawarna, S. A.; Guha-Biswas, M.; Nelson, W. L. J. Heterocycl. Chem. 1991, 28, 1395.
18. (d) Larrow, J. F.; Jacobsen, E. N.; Gao, Y.; Hong, Y.; Nie, X.; Zepp, C. M. J. Org. Chem. 1994, 59, 1939.
19. 2 (4 × 1865 mL), and the combined organic layers were concentrated to an oil. Addition of 135 mL of EtOH resulted in the crystallization of 2 as a light yellow solid, which was then washed with cold EtOH (2 × 50 mL), filtered, and dried to give 2 (56.64 g, 377 mmol) in 38.5% yield. The resultant filtrate was concentrated to a slurry, filtered, washed with EtOH (3 × 20 mL), and dried to give additional 2 (13.93 g, 93 mmol, 9.5% yield), which had a lower potency.
20. 13C NMR, IR, and elemental analysis data were obtained for all reaction products.
21. 12. Royer, R.; Bisgani, E.; Hudry, C. J. Org. Chem. 1961, 26, 4308.
22. 13. Sabitha, G.; Rao, A. V. S. Synth. Commun. 1987, 17, 341.
23. 2O/MeCN; 2:1 (2 × 1.5 L), MeCN (2 × 1.5 L), and then dried in vacuo at 50-60 °C overnight to give 7b (425 g, 1.42 mol) in 94% yield.
24. 15. Menassé, R.; Klein, G.; Erlenmeyer, H. Helv. Chim. Acta 1955, 38, 1289.
25. 16. An effective ISE compound developed by Takeda Chemical Industries is Pioglitazone, which contains a pyridine moiety. Momose, Y.; Meguro, K.; Ikeda, H.; Hatanaka, C; Oi, S.; Sohda, T. Chem. Pharm. Bull. 1991, 39, 1440.
26. 17. (a) Burke, J. M.; Stevenson, R. J. Nat. Products 1986, 49, 522.
27. (b) Reisch, J.; Gunaherath, G. M. K. B. J. Chem. Soc. Perkin Trans. 1 1989, 1047.
28. (c) MacLeod, J. K.; Worth, B. R.; Wells, R. J. Aust. J. Chem. 1978, 31, 1533.
29. (d) Elix, J. A. Aust. J. Chem. 1971, 24, 93.